3s53: Difference between revisions

Revision as of 05:26, 1 June 2011 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,330,058 edits m Protected "3s53" [edit=sysop:move=sysop] ← Older edit		Revision as of 04:53, 8 June 2011 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,330,058 edits No edit summary Newer edit →
Line 5:		Line 5:
	Authors: Tie, Y.-F., Wang, Y.-F., Weber, I.T.		Authors: Tie, Y.-F., Wang, Y.-F., Weber, I.T.

	Description: HIV-1 ~~PROTEASE TRIPLE MUTANTS~~ V32I, I47V, V82I ~~WITH ANTIVIRAL DRUG DARUNAVIR~~ in ~~SPACE GROUP~~ P212121		Description: HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P212121

Navigation menu